Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 11
1998 7
1999 7
2000 4
2001 6
2002 3
2003 3
2004 3
2005 4
2006 3
2007 4
2008 5
2009 7
2010 5
2011 9
2012 5
2013 6
2014 8
2015 8
2016 8
2017 12
2018 11
2019 18
2020 13
2021 17
2022 9
2023 12
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Primary presentation and clinical course of pediatric and adolescent patients with differentiated thyroid carcinoma after radioiodine therapy.
Burgard C, Zacherl MJ, Todica A, Hornung J, Grawe F, Pekrul I, Zimmermann P, Schmid-Tannwald C, Ladurner R, Krenz D, Trupka A, Wagner J, Bartenstein P, Spitzweg C, Wenter V. Burgard C, et al. Among authors: spitzweg c. Front Oncol. 2023 Oct 2;13:1237472. doi: 10.3389/fonc.2023.1237472. eCollection 2023. Front Oncol. 2023. PMID: 37849815 Free PMC article.
Diagnostic accuracy of SSR-PET/CT compared to histopathology in the identification of liver metastases from well-differentiated neuroendocrine tumors.
Fabritius MP, Soltani V, Cyran CC, Ricke J, Bartenstein P, Auernhammer CJ, Spitzweg C, Schnitzer ML, Ebner R, Mansournia S, Hinterberger A, Lohse A, Sheikh GT, Winkelmann M, Knösel T, Ingenerf M, Schmid-Tannwald C, Kunz WG, Rübenthaler J, Grawe F. Fabritius MP, et al. Among authors: spitzweg c. Cancer Imaging. 2023 Sep 28;23(1):92. doi: 10.1186/s40644-023-00614-2. Cancer Imaging. 2023. PMID: 37770958 Free PMC article.
Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.
Kitzberger C, Shehzad K, Morath V, Spellerberg R, Ranke J, Steiger K, Kälin RE, Multhoff G, Eiber M, Schilling F, Glass R, Weber WA, Wagner E, Nelson PJ, Spitzweg C. Kitzberger C, et al. Among authors: spitzweg c. Mol Ther Oncolytics. 2023 Aug 15;30:238-253. doi: 10.1016/j.omto.2023.08.004. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37701849 Free PMC article.
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer.
Koehler VF, Achterfeld J, Sandner N, Koch C, Wiegmann JP, Ivanyi P, Käsmann L, Pusch R, Wolf D, Chirica M, Knösel T, Demes MC, Kumbrink J, Vogl TJ, Meyer G, Spitzweg C, Bojunga J, Kroiss M. Koehler VF, et al. Among authors: spitzweg c. J Cancer Res Clin Oncol. 2023 Nov;149(15):14035-14043. doi: 10.1007/s00432-023-05134-x. Epub 2023 Aug 7. J Cancer Res Clin Oncol. 2023. PMID: 37548775 Free PMC article.
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients.
Grawe F, Ebner R, Geyer T, Beyer L, Winkelmann M, Sheikh GT, Eschbach R, Schmid-Tannwald C, Cyran CC, Ricke J, Bartenstein P, Heimer MM, Faggioni L, Spitzweg C, Fabritius MP, Auernhammer CJ, Ruebenthaler J. Grawe F, et al. Among authors: spitzweg c. Eur Radiol. 2023 May;33(5):3416-3424. doi: 10.1007/s00330-023-09518-y. Epub 2023 Mar 25. Eur Radiol. 2023. PMID: 36964768 Free PMC article.
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE.
Eschbach RS, Hofmann M, Späth L, Sheikh GT, Delker A, Lindner S, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Tiling R, Brendel M, Wenter V, Dekorsy FJ, Zacherl MJ, Todica A, Ilhan H, Grawe F, Cyran CC, Unterrainer M, Rübenthaler J, Knösel T, Paul T, Boeck S, Westphalen CB, Spitzweg C, Auernhammer CJ, Bartenstein P, Unterrainer LM, Beyer L. Eschbach RS, et al. Among authors: spitzweg c. Front Oncol. 2023 Jan 30;13:992316. doi: 10.3389/fonc.2023.992316. eCollection 2023. Front Oncol. 2023. PMID: 36793617 Free PMC article.
Dermacentor reticulatus - a tick on its way from glacial refugia to a panmictic Eurasian population.
Bilbija B, Spitzweg C, Papoušek I, Fritz U, Földvári G, Mullett M, Ihlow F, Sprong H, Civáňová Křížová K, Anisimov N, Belova OA, Bonnet SI, Bychkova E, Czułowska A, Duscher GG, Fonville M, Kahl O, Karbowiak G, Kholodilov IS, Kiewra D, Krčmar S, Kumisbek G, Livanova N, Majláth I, Manfredi MT, Mihalca AD, Miró G, Moutailler S, Nebogatkin IV, Tomanović S, Vatansever Z, Yakovich M, Zanzani S, Široký P. Bilbija B, et al. Among authors: spitzweg c. Int J Parasitol. 2023 Feb;53(2):91-101. doi: 10.1016/j.ijpara.2022.11.002. Epub 2022 Dec 19. Int J Parasitol. 2023. PMID: 36549441 Free article.
Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.
Kitzberger C, Spellerberg R, Han Y, Schmohl KA, Stauss C, Zach C, Kälin RE, Multhoff G, Eiber M, Schilling F, Glass R, Weber WA, Wagner E, Nelson PJ, Spitzweg C. Kitzberger C, et al. Among authors: spitzweg c. Clin Cancer Res. 2023 Mar 1;29(5):930-942. doi: 10.1158/1078-0432.CCR-22-1433. Clin Cancer Res. 2023. PMID: 36516189
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma.
Spellerberg R, Benli-Hoppe T, Kitzberger C, Hageneier M, Schwenk N, Öztürk Ö, Steiger K, Multhoff G, Eiber M, Schilling F, Weber WA, Kälin RE, Glass R, Nelson PJ, Wagner E, Spitzweg C. Spellerberg R, et al. Among authors: spitzweg c. Mol Ther Oncolytics. 2022 Nov 3;27:272-287. doi: 10.1016/j.omto.2022.10.013. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36458201 Free PMC article.
189 results